v3.25.2
SEGMENTED INFORMATION
9 Months Ended
Jun. 30, 2025
SEGMENTED INFORMATION  
SEGMENTED INFORMATION

10.    SEGMENTED INFORMATION

The Company works in one industry being the development of small molecule drugs for prostate cancer. The Company’s right of use assets were located in the USA.